PMC:7195088 / 6416-6734 JSONTXT

Annnotations TAB JSON ListView MergeView

    LitCovid-PubTator

    {"project":"LitCovid-PubTator","denotations":[{"id":"157","span":{"begin":308,"end":316},"obj":"Species"},{"id":"184","span":{"begin":135,"end":144},"obj":"Species"},{"id":"195","span":{"begin":38,"end":49},"obj":"Chemical"},{"id":"196","span":{"begin":53,"end":62},"obj":"Chemical"},{"id":"197","span":{"begin":165,"end":195},"obj":"Chemical"},{"id":"198","span":{"begin":248,"end":266},"obj":"Chemical"}],"attributes":[{"id":"A157","pred":"tao:has_database_id","subj":"157","obj":"Tax:9606"},{"id":"A184","pred":"tao:has_database_id","subj":"184","obj":"Tax:11520"},{"id":"A195","pred":"tao:has_database_id","subj":"195","obj":"MESH:D053139"},{"id":"A196","pred":"tao:has_database_id","subj":"196","obj":"MESH:D053243"},{"id":"A198","pred":"tao:has_database_id","subj":"198","obj":"MESH:D006886"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"e not approved for other indications. Oseltamivir or zanamivir should be provided only in the presence of suspected/proven concomitant influenza.\nQuestion 3. Should chloroquine/hydroxychloroquine be administered? Pending results of RCT, the use of hydroxychloroquine may be considered for treating worsening patients w"}

    LitCovid-PD-MONDO

    {"project":"LitCovid-PD-MONDO","denotations":[{"id":"T26","span":{"begin":135,"end":144},"obj":"Disease"}],"attributes":[{"id":"A26","pred":"mondo_id","subj":"T26","obj":"http://purl.obolibrary.org/obo/MONDO_0005812"}],"text":"e not approved for other indications. Oseltamivir or zanamivir should be provided only in the presence of suspected/proven concomitant influenza.\nQuestion 3. Should chloroquine/hydroxychloroquine be administered? Pending results of RCT, the use of hydroxychloroquine may be considered for treating worsening patients w"}

    LitCovid-PD-CHEBI

    {"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T24","span":{"begin":38,"end":49},"obj":"Chemical"},{"id":"T25","span":{"begin":53,"end":62},"obj":"Chemical"},{"id":"T26","span":{"begin":165,"end":176},"obj":"Chemical"},{"id":"T27","span":{"begin":177,"end":195},"obj":"Chemical"},{"id":"T28","span":{"begin":248,"end":266},"obj":"Chemical"}],"attributes":[{"id":"A24","pred":"chebi_id","subj":"T24","obj":"http://purl.obolibrary.org/obo/CHEBI_7798"},{"id":"A25","pred":"chebi_id","subj":"T25","obj":"http://purl.obolibrary.org/obo/CHEBI_50663"},{"id":"A26","pred":"chebi_id","subj":"T26","obj":"http://purl.obolibrary.org/obo/CHEBI_3638"},{"id":"A27","pred":"chebi_id","subj":"T27","obj":"http://purl.obolibrary.org/obo/CHEBI_5801"},{"id":"A28","pred":"chebi_id","subj":"T28","obj":"http://purl.obolibrary.org/obo/CHEBI_5801"}],"text":"e not approved for other indications. Oseltamivir or zanamivir should be provided only in the presence of suspected/proven concomitant influenza.\nQuestion 3. Should chloroquine/hydroxychloroquine be administered? Pending results of RCT, the use of hydroxychloroquine may be considered for treating worsening patients w"}

    LitCovid-sentences

    {"project":"LitCovid-sentences","denotations":[{"id":"T45","span":{"begin":38,"end":145},"obj":"Sentence"},{"id":"T46","span":{"begin":146,"end":157},"obj":"Sentence"},{"id":"T47","span":{"begin":158,"end":212},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"e not approved for other indications. Oseltamivir or zanamivir should be provided only in the presence of suspected/proven concomitant influenza.\nQuestion 3. Should chloroquine/hydroxychloroquine be administered? Pending results of RCT, the use of hydroxychloroquine may be considered for treating worsening patients w"}